Ifosfamide encephalopathy: a reappraisal
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (9) , 1303-1310
- https://doi.org/10.1016/0277-5379(89)90077-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- ENCEPHALOPATHY WITH RAPID INFUSION IFOSFAMIDE/MESNAThe Lancet, 1987
- DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITYThe Lancet, 1986
- AVOIDING IFOSFAMIDE/MESNA ENCEPHALOPATHYThe Lancet, 1986
- Prediction of Ifosfamide/Mesna associated encephalopathyEuropean Journal of Cancer and Clinical Oncology, 1986
- IFOSFAMIDE/MESNA AND ENCEPHALOPATHYThe Lancet, 1985
- ENCEPHALOPATHY ASSOCIATED WITH IFOSPHAMIDE/MESNA THERAPYThe Lancet, 1985
- Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patientsCancer Treatment Reviews, 1983
- The development of mesna for regional detoxificationCancer Treatment Reviews, 1983
- High-dose ifosfamide and mesna as continuous infusion over five days—a phase I/II trialCancer Treatment Reviews, 1983
- Central nervous side effects following ifosfamide monotherapy of advanced renal carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1981